Advertisement
INM vs KMDA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INM is a Hold and KMDA is a Hold.
Momentum Indicator for INM turns negative, indicating new downward trend
INM saw its Momentum Indicator move below the 0 level on October 13, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned negative. In 89 of the 94 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for INM entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for INM just turned positive on September 17, 2026. Looking at past instances where INM's MACD turned positive, the stock continued to rise in 39 of 45 cases over the following month. The odds of a continued upward trend are 87%.
Following a +2.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where INM advanced for three days, in 154 of 187 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.746) is normal, around the industry mean (43.873). P/E Ratio (-0.423) is within average values for comparable stocks, (141.710). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.891) is also within normal values, averaging (178.797).
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. INM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
KMDA in downward trend: 10-day moving average broke below 50-day moving average on October 13, 2026
The 10-day moving average for KMDA crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KMDA as a result. In 57 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 56%.
The Moving Average Convergence Divergence Histogram (MACD) for KMDA turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 34 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.
KMDA moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KMDA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 68 cases where KMDA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The 50-day moving average for KMDA moved above the 200-day moving average on September 24, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +8.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where KMDA advanced for three days, in 176 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
KMDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 95 of 160 cases where KMDA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.661) is normal, around the industry mean (43.873). P/E Ratio (20.421) is within average values for comparable stocks, (141.710). Projected Growth (PEG Ratio) (0.644) is also within normal values, averaging (2.152). KMDA's Dividend Yield (0.088) is considerably higher than the industry average of (0.005). P/S Ratio (2.487) is also within normal values, averaging (178.797).
The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 45 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. KMDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 76 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
INM | KMDA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 40 Fair valued | 6 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 45 | |
SMR RATING 1..100 | 99 | 76 | |
PRICE GROWTH RATING 1..100 | 42 | 48 | |
P/E GROWTH RATING 1..100 | 73 | 33 | |
SEASONALITY SCORE 1..100 | 90 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
KMDA's Valuation (6) in the Biotechnology industry is somewhat better than the same rating for INM (40) in the null industry. This means that KMDA’s stock grew somewhat faster than INM’s over the last 12 months.
KMDA's Profit vs Risk Rating (45) in the Biotechnology industry is somewhat better than the same rating for INM (100) in the null industry. This means that KMDA’s stock grew somewhat faster than INM’s over the last 12 months.
KMDA's SMR Rating (76) in the Biotechnology industry is in the same range as INM (99) in the null industry. This means that KMDA’s stock grew similarly to INM’s over the last 12 months.
INM's Price Growth Rating (42) in the null industry is in the same range as KMDA (48) in the Biotechnology industry. This means that INM’s stock grew similarly to KMDA’s over the last 12 months.
KMDA's P/E Growth Rating (33) in the Biotechnology industry is somewhat better than the same rating for INM (73) in the null industry. This means that KMDA’s stock grew somewhat faster than INM’s over the last 12 months.
| INM | KMDA | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 3 days ago 87% | 3 days ago 68% |
| Momentum ODDS (%) | 3 days ago 90% | 3 days ago 56% |
| MACD ODDS (%) | 3 days ago 87% | 3 days ago 65% |
| TrendWeek ODDS (%) | 3 days ago 90% | 3 days ago 63% |
| TrendMonth ODDS (%) | 3 days ago 80% | 3 days ago 65% |
| Advances ODDS (%) | 27 days ago 82% | about 1 month ago 69% |
| Declines ODDS (%) | 5 days ago 90% | 5 days ago 62% |
| BollingerBands ODDS (%) | N/A | 3 days ago 73% |
| Aroon ODDS (%) | 3 days ago 90% | 3 days ago 59% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
INM’s FA Score shows that 0 FA rating(s) are green while KMDA’s FA Score has 2 green FA rating(s).
- INM’s FA Score: 0 green, 5 red.
- KMDA’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
INM’s TA Score shows that 3 TA indicator(s) are bullish while KMDA’s TA Score has 5 bullish TA indicator(s).
- INM’s TA Score: 3 bullish, 3 bearish.
- KMDA’s TA Score: 5 bullish, 5 bearish.
Price Growth
INM (@Pharmaceuticals: Generic) experienced а -2.94% price change this week, while KMDA (@Pharmaceuticals: Generic) price change was -3.96% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -6.95%. For the same industry, the average monthly price growth was -5.23%, and the average quarterly price growth was +10.96%.
Reported Earning Dates
KMDA is expected to report earnings on Nov 16, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-6.95% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
What are realistic expectations for my portfolio performance?
What is Mutual Fund Classification According to the Price to Earnings Ratio?
What Qualifies You as a "Trader," and How Do You Report Income and Expenses?
Starting a Portfolio? Why ETFs Are a Smart Choice
Decoding the Descending Triangle (Bearish) Pattern in Stock Trading
INM and
Correlation & Price change
A.I.dvisor indicates that over the last year, INM has been loosely correlated with HYPD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if INM jumps, then HYPD could also see price increases.
| Ticker / NAME | Correlation To INM | 1D Price Change % | ||
|---|---|---|---|---|
| INM | 100% | -0.75% | ||
| HYPD - INM | 39% Loosely correlated | -9.84% | ||
| OMER - INM | 36% Loosely correlated | -13.78% | ||
| PULM - INM | 30% Poorly correlated | -4.23% | ||
| IXHL - INM | 28% Poorly correlated | -2.08% | ||
| CRDF - INM | 28% Poorly correlated | -7.20% | ||
More | ||||
KMDA and
Correlation & Price change
A.I.dvisor tells us that KMDA and TEVA have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and TEVA's prices will move in lockstep.
| Ticker / NAME | Correlation To KMDA | 1D Price Change % | ||
|---|---|---|---|---|
| KMDA | 100% | -0.89% | ||
| TEVA - KMDA | 25% Poorly correlated | +0.95% | ||
| CRDL - KMDA | 25% Poorly correlated | -4.35% | ||
| INM - KMDA | 25% Poorly correlated | -0.75% | ||
| OGI - KMDA | 25% Poorly correlated | -0.53% | ||
| ELAN - KMDA | 25% Poorly correlated | +0.04% | ||
More | ||||